The Medicines Patent Pool today announced the launch of MedsPaL, its Medicines Patents & Licences Database, a new resource for information on the intellectual property status of priority medicines in developing countries.
MedsPaL offers up-to-date patent data
MedsPaL was introduced at the World Intellectual Property Organization (WIPO) General Assemblies. MedsPaL replaces MPP’s signature HIV patent status database and includes patent and licensing data on HIV, hepatitis C and tuberculosis treatments covering 4,000 national patent applications in more than 100 low- and middle-income countries (LMICs).
Commenting on the launch, IDA Foundation's CEO Edwin de Voogd said: “Access to comprehensive, updated patent information is essential for supplying customers worldwide and particularly those in middle-income countries. IDA Foundation has long relied on the Medicines Patent Pool for data related to HIV drugs. We welcome the launch of MedsPaL and the inclusion of Hepatitis C and tuberculosis medicines in this new database.”
For the full press release, see ow.ly/DKXv304SkAT